Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Oxygenation and Inflammatory Markers after Early Covid-19 Convalescent Plasma: A Comparison of Survivors and Non-Survivors

Valentina Baez Sosa, Ahmad M Nassar, Nikitha Vobugari, Anjali S Ghodasara, Cathy Conry-Cantilena, Glenn Wortmann, Emily R Fischer, Stephen Fernandez, Sameer Desale, Lorraine Wyne, Brandon G Clark, Aarthi Shenoy

Blood (2021) 138 (Supplement 1): 4277.

https://doi.org/10.1182/blood-2021-152894

Published: 2021

Journal Articles

Leveraging the Power of a Healthcare System to Fulfill the COVID Convalescent Plasma Needs Early in the COVID-19 Pandemic

Valentina Baez Sosa, MD, Cathy Conry-Cantilena, MD, Glenn Wortmann, Emily R Fischer, Brandon G Clark, Lorraine Wyne, Aarthi Shenoy, MD

Blood (2020) 136 (Supplement 1): 24–25.

https://doi.org/10.1182/blood-2020-138948

Published: 2020

Journal Articles

Activated mouse eosinophils protect against lethal respiratory virus infection

Caroline M. Percopo, Kimberly D. Dyer, Sergei I. Ochkur, Janice L. Luo, Elizabeth R. Fischer, James J. Lee, Nancy A. Lee, Joseph B. Domachowske, Helene F. Rosenberg

Blood (2014) 123 (5): 743–752.

https://doi.org/10.1182/blood-2013-05-502443

Published: 2014

Journal Articles

Pneumoviruses infect eosinophils and elicit MyD88-dependent release of chemoattractant cytokines and interleukin-6

Kimberly D. Dyer, Caroline M. Percopo, Elizabeth R. Fischer, Stanislaw J. Gabryszewski, Helene F. Rosenberg

Blood (2009) 114 (13): 2649–2656.

https://doi.org/10.1182/blood-2009-01-199497

Published: 2009

Includes: Supplemental data

Journal Articles

A Randomized, Controlled Phase II Trial in Sickle Cell Disease Patients with Chronic Iron Overload Demonstrates That the Once-Daily Oral Iron Chelator Deferasirox (Exjade ® , ICL670) Is Well Tolerated and Reduces Iron Burden.

E. Vichinsky, R. Fischer, E. Fung, O. Onyekwere, J. Porter, P. Swerdlow, T. Coates, P. Lane, B. Files, B. U. Mueller, F. Bernaudin, G. L. Forni, C. Ressayre-Djaffer, I. Gathmann, J. Holland, D. Alberti, P. Marks

Blood (2005) 106 (11): 313.

https://doi.org/10.1182/blood.V106.11.313.313

Published: 2005

Journal Articles

Comparison of LIC Obtained from Biopsy, BLS and R 2 -MRI in Iron Overloaded Patients with β-Thalassemia, Treated with Deferasirox (Exjade®, ICL670).

Blood (2005) 106 (11): 2689.

https://doi.org/10.1182/blood.V106.11.2689.2689

Published: 2005

Journal Articles

Satisfaction and Convenience of Chelation Therapy in Patients with Sickle Cell Disease (SCD): Comparison between Deferasirox (Exjade ® , ICL670) and Deferoxamine (DFO).

E. Vichinsky, R. Fischer, Z. Pakbaz, O. Onyekwere, J. Porter, P. Swerdlow, T. Coates, P. Lane, B. Files, B.U. Mueller, L. Coïc, G. Forni, L. Abetz, J.F. Baladi, C. Ressayre-Djaffer, I. Gathmann, D. Alberti, P. Marks

Blood (2005) 106 (11): 2334.

https://doi.org/10.1182/blood.V106.11.2334.2334

Published: 2005

Journal Articles

Tissue eosinophilia correlates strongly with poor prognosis in nodular sclerosing Hodgkin's disease, allowing for known prognostic factors

R. von Wasielewski, S. Seth, J. Franklin, R. Fischer, K. Hübner, M. L. Hansmann, V. Diehl, A. Georgii

Blood (2000) 95 (4): 1207–1213.

https://doi.org/10.1182/blood.V95.4.1207.004k34_1207_1213

Published: 2000

Journal Articles

Secretion of cytokines (interleukins-1 alpha, -3, and -6 and granulocyte-macrophage colony-stimulating factor) by normal human bone marrow megakaryocytes

C Wickenhauser, J Lorenzen, J Thiele, A Hillienhof, K Jungheim, B Schmitz, ML Hansmann, R Fischer

Blood (1995) 85 (3): 685–691.

https://doi.org/10.1182/blood.V85.3.685.bloodjournal853685

Published: 1995

Journal Articles

Purification and characterization of heterogeneous pluripotent hematopoietic stem cell populations expressing high levels of c-kit receptor

D Orlic, R Fischer, S Nishikawa, AW Nienhuis, DM Bodine

Blood (1993) 82 (3): 762–770.

https://doi.org/10.1182/blood.V82.3.762.762

Published: 1993

Journal Articles

Studies of the terminal stages of hemoglobin synthesis: I. Stimulation of globin chain synthesis by native hemoglobin subunits

RN Rubin, SK Ballas, R Fischer, KH Winterhalter, ER Burka

Blood (1979) 53 (1): 148–156.

https://doi.org/10.1182/blood.V53.1.148.148

Published: 1979

NARROW

Oxygenation and Inflammatory Markers after Early Covid-19 Convalescent Plasma: A Comparison of Survivors and Non-Survivors

Leveraging the Power of a Healthcare System to Fulfill the COVID Convalescent Plasma Needs Early in the COVID-19 Pandemic

Activated mouse eosinophils protect against lethal respiratory virus infection

Pneumoviruses infect eosinophils and elicit MyD88-dependent release of chemoattractant cytokines and interleukin-6

A Randomized, Controlled Phase II Trial in Sickle Cell Disease Patients with Chronic Iron Overload Demonstrates That the Once-Daily Oral Iron Chelator Deferasirox (Exjade ® , ICL670) Is Well Tolerated and Reduces Iron Burden.

Comparison of LIC Obtained from Biopsy, BLS and R 2 -MRI in Iron Overloaded Patients with β-Thalassemia, Treated with Deferasirox (Exjade®, ICL670).

Satisfaction and Convenience of Chelation Therapy in Patients with Sickle Cell Disease (SCD): Comparison between Deferasirox (Exjade ® , ICL670) and Deferoxamine (DFO).

Tissue eosinophilia correlates strongly with poor prognosis in nodular sclerosing Hodgkin's disease, allowing for known prognostic factors

Secretion of cytokines (interleukins-1 alpha, -3, and -6 and granulocyte-macrophage colony-stimulating factor) by normal human bone marrow megakaryocytes

Purification and characterization of heterogeneous pluripotent hematopoietic stem cell populations expressing high levels of c-kit receptor

Studies of the terminal stages of hemoglobin synthesis: I. Stimulation of globin chain synthesis by native hemoglobin subunits

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only